In this Issue
New device options offer solutions for more AAA patients, but questions regarding ideal applications remain.
More EVAR Options, But Also More Questions
By Ronald M. Fairman, MD, and Edward Y. Woo, MD
Steady evolution in device design and delivery has expanded endovascular repair to more patients, but further advancements are integral to this technology’s future.
By Eanas S. Yassa, MD, and Joseph V. Lombardi, MD
Essential factors determining EVAR durability at the proximal sealing zone.
By Robert Y. Rhee, MD
The advantages afforded with suprarenal fixation when treating abdominal aortic aneurysms.
By Benjamin M. Jackson, MD, and Ronald M. Fairman, MD
Advanced endovascular techniques and specialized devices in the pipeline are making fenestrated EVAR a viable option in this challenging anatomic site.
By Nikolaos Tsilimparis, MD, and Joseph J. Ricotta II, MD, MS
Hybrid repair is an alternative in patients who are not candidates for open surgery or total endovascular approaches.
By Gustavo S. Oderich, MD
Standardized technology allows interventionists to treat patients on an individual basis with the most appropriate device indicated for aneurysm presentations.
By Samir K. Shah, MD; Timothy Resch, MD, PhD; and Daniel G. Clair, MD
Long-term data for off-the-shelf devices remain uncertain, and their durability for challenging anatomy should be considered.
By Tara M. Mastracci, MD, and Roy K. Greenberg, MD
How iliac branch grafting may become a first-line treatment option.
By Erin H. Murphy, MD, and Edward Y. Woo, MD
EVAR device profiles are getting smaller, and access techniques are becoming more refined, but are we there yet?
By Yiu Che Chan, MB BS, BSc, MD, FRCS (Eng), FRCS (Gen Surg) FCSHK, and Stephen W. K. Cheng, MB BS, MS, FRCS (Eng), FRCS (Edin), FCSHK, FHKAM
Successful endoleak resolution after endovascular abdominal aortic aneurysm repair.
By Ripal T. Gandhi, MD, and Barry T. Katzen, MD, FACC, FACR, FSIR
What makes a patient a good candidate or a noncandidate, how we know, and whether that has changed in the past 5 years.
By Jose I. Almeida, MD, FACS, RPVI, RVT, and Cristal Boatright, MMS, PA-C
Vein closure in patients with a history of deep vein thrombosis is achievable and may lead to beneficial results, but further research is needed.
By Rafi Jarjous, BS; Angelica Reihmer, BS; Farah Jarjous, BS; and George T. Nahhas, MD, FACC, RPVI
The Director of the Vascular Medicine Program at the University of Minnesota shares his thoughts on the role of exercise therapy in treating PAD, as well as spreading PAD awareness to the public, specifically, the underserved population of women.